Babesia gibsoni (IFA)
The Babesia gibsoni IFA test is used to detect antibodies against Babesia gibsoni, a protozoan parasite that causes canine babesiosis. This test employs the indirect fluorescent antibody (IFA), which is highly sensitive and specific for identifying exposure to B. gibsoni. The detection of antibodies indicates prior or active infection, enabling to diagnose babesiosis accurately and initiate treatment promptly. This IFA test is particularly valuable in regions where tick-borne infections are prevalent and in animals showing symptoms consistent with babesiosis.
Additionally, this test plays a critical role in pet travel compliance, as some countries require proof of a negative result for Brucella gibsoni as part of their import regulations.
Test name
Babesia gibsoni (IFA)
Test Code
4009
Section
Immunodiagnostics
Species
Canine
Specimen
2 ml Serum
Collection Guidelines
- Collect an adequate amount of blood in a plain red-top tube or serum separator tube (yellow-top tube). Allow it to clot at room temperature for 30 to 60 minutes before separation.
- Centrifuge to separate the serum. Transfer the clear serum into a new, leak-proof plain red-top tube and label it as “serum.”
- Excessively hemolyzed samples are not suitable for this test.
- Unspun samples will not be accepted.
- Refrigerate sample at 4oC until shipment.
Turnaround time
14-21 days
Packing Instructions
Label each sample with the animal’s name and a unique identifier, using a permanent marker or a secure adhesive label. Ensure the submittal form is completed with the animal’s information and relevant medical history.
References
- Birkenheuer, A.J., et al. “Clinical Relevance of Babesia gibsoni in Canine Babesiosis: Diagnosis and Management.” Journal of Veterinary Internal Medicine, 2021.
- Jefferies, R., et al. “Advances in Diagnostic Approaches for Canine Babesiosis.” Veterinary Clinics of North America: Small Animal Practice, 2022.
- Irwin, P.J., et al. “Use of IFA in the Diagnosis of Babesia gibsoni in Dogs.” Journal of Veterinary Diagnostic Investigation, 2023.
